{"id":56569,"date":"2024-02-27T16:59:23","date_gmt":"2024-02-27T16:59:23","guid":{"rendered":"https:\/\/medsname.com\/desowen\/"},"modified":"2026-05-01T10:49:13","modified_gmt":"2026-05-01T10:49:13","slug":"desowen","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/desowen\/","title":{"rendered":"Desowen"},"content":{"rendered":"

<\/p>\n

\n

⚡ Quick Answer — What is Desowen?<\/h3>\n

Desowen<\/strong> bevat desonide 0.05%<\/strong> as a topical lotion from Galderma — a mild \/ low-potency topical corticosteroid (UK Class I \/ US Class VII-VI)<\/strong>. Because it is mild, desonide is one of the safest topical steroids for use on the face, eyelids (with dermatology guidance), neck, intertriginous folds, and in paediatric patients (including infants 3 months and older)<\/strong>. Het wordt gebruikt voor atopic dermatitis (eczema), seborrhoeic dermatitis, contact dermatitis, intertrigo, discoid lupus<\/strong>, and other steroid-responsive inflammatory skin conditions where a mild steroid is sufficient or where a potent steroid would cause atrophy. Apply a thin film twice daily<\/strong> for up to 4 weeks on body sites, 2 weeks on the face, 1 week on eyelids or intertriginous zones. Desonide’s favourable safety margin makes it a first-choice steroid in paediatric dermatology, but it should still be used under guidance for the shortest necessary course.<\/p>\n<\/div>\n

\nWat u krijgt bij MedsBase:<\/strong> WHO-GMP gecertificeerde fabrikant \u00b7 Discrete verpakking \u00b7 Wereldwijde verzending \u00b7 1.400+ geverifieerde klantbeoordelingen<\/a>\n<\/div>\n

\ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n

Waarom bestellen bij MedsBase<\/h3>\n

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen \u2014 geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor \u2014 nooit \u201cMedsBase\u201d of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.<\/p>\n

What Is Desowen?<\/h2>\n

Desowen is a topical desonide 0.05%<\/strong> lotion from Galderma supplied in a 30 mL lotion. Desonide is a synthetic non-fluorinated glucocorticoid classified as a low-potency topical corticosteroid<\/strong> (UK Class I \/ US Class VI-VII, sometimes called “mild” on European potency scales). It is the molecule of choice when facial, paediatric, or intertriginous application demands a safety profile that moderate and potent steroids cannot offer.<\/p>\n

Internationaal verkocht onder de merknaam Desowen, DesoRx, Verdeso (foam), Tridesilon<\/strong> (US); Desowen is the Galderma version available through MedsBase with worldwide shipping.<\/p>\n

Topical Steroid Potency Ladder — Where Desonide Sits<\/h2>\n\n\n\n\n\n\n\n\n
UK Class<\/th>\nUS Class<\/th>\nExamples<\/th>\n<\/tr>\n<\/thead>\n
I (mild)<\/td>\nVII-VI<\/td>\nHydrocortisone 0.5-1%, desonide 0.05% (Desowen)<\/strong><\/td>\n<\/tr>\n
II (moderate)<\/td>\nV<\/td>\nClobetasone butyrate, betamethasone valerate 0.025%<\/td>\n<\/tr>\n
III (potent)<\/td>\nIII-II<\/td>\nBetamethasone valerate 0.1% (Betnovate<\/strong>), mometasone 0.1% (Elocon<\/a>, Momin<\/a>), fluticasone (Flutivate<\/a>)<\/td>\n<\/tr>\n
IV (super-potent)<\/td>\nI<\/td>\nClobetasol propionate 0.05% (Tenovate<\/a>), halobetasol propionate 0.05% (Halox<\/a>)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Desonide sits in the mildest tier alongside hydrocortisone 0.5-1%. The key advantage over hydrocortisone is that desonide is non-halogenated<\/strong> — meaning it has one of the lowest skin-atrophy and telangiectasia risks of any topical steroid, making it appropriate for thin-skin areas (face, eyelids, paediatric) where potent steroids are contraindicated.<\/p>\n

How Desowen Works<\/h2>\n

Desonide binds intracellular glucocorticoid receptors in keratinocytes and infiltrating inflammatory cells. The activated receptor complex enters the nucleus and downregulates pro-inflammatory cytokine transcription (IL-1, IL-2, IL-6, TNF-α), suppresses phospholipase A2<\/sub> (reducing prostaglandin\/leukotriene synthesis), and triggers apoptosis of activated T-lymphocytes — resolving the itch-redness-inflammation cycle of eczema and related dermatoses.<\/p>\n

Onset: itch and redness begin to improve in 24-48 hours; full effect within 1-2 weeks.<\/p>\n

Goedgekeurde en evidence-based toepassingen<\/h2>\n